4.4 Article

Changes in Dendritic Cell Phenotype After a New High-dose Weekly Schedule of Interleukin-2 Therapy for Kidney Cancer and Melanoma

Related references

Note: Only part of the references are listed.
Article Immunology

Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells

DI Gabrilovich et al.

JOURNAL OF IMMUNOLOGY (2001)